Given the many challenges Europe is currently facing, defense and security have naturally risen to the top of the EU political agenda. In a tense geopolitical context, with a war on its doorstep and t...

26 Oct 2023 14:00 to 15:00   EUCOPE together with Novartis Gene Therapies, is organising an in-person expert briefing session hosted by MEP Radka Maxová (S&D, CZ).   The session will take place on 26 October from 14.00 – 15.00 CET, at the European Parliament (room 3H1). The session will focus on the complexities surrounding developing and producing paediatric medicines in Europe. Additionally, it will seek to underscore the possibilities for establishing a European framework that facilitates quicker patient access to these medications.  Experts in the field will delve into the discussion around the challenges involved in identifying paediatric needs, the potential solutions that could further strengthen the innovation in paediatric development , and how a multistakeholder collaboration can foster an environment where paediatric therapies receive holistic attention and development, by bringing more investments in the EU's research and ultimately benefiting patients.    Day and Time: 26rd October – 14:00 – 15:00 CET Location: European Parliament (room 3H1)   REGISTER HERE!   SPEAKERS The speaker panel will be joined by Fabio D’Atri (D1 - Medicines: Policy, authorisation and monitoring - Policy Officer), Martine Pergent, (President of Patient Organisation for Primary Immunodeficiency), Pauline Roudot (Associate Director Regulatory Policy & Intelligence, Novartis), and Saskia N. de Wildt (Professor of Clinical Pharmacology at Radboud University).   In order to process and grant access to the European Parliament the organisers will require some personal details to be shared with the EP service.   Brussels European Parliament Room 3H1    Brussels Belgium More information here

Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe